PCDHB14 inhibits HCC progression by enhancing RNF182-mediated degradation of p65 and promotes cell sensitivity to ferroptosis in HCC by suppressing SLC7A11.129. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.